Cargando…
Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
Transfusion-related complications and lack of resources in low-to-middle-income countries have led to a search for novel therapies to reduce the need for blood transfusions in patients with β-thalassemia. Hydroxyurea (HU) has demonstrated promising outcomes; additionally, thalidomide has also shown...
Autores principales: | Ansari, Saqib H., Ansari, Iqra, Wasim, Misbah, Sattar, Amjad, Khawaja, Shariqa, Zohaib, Muhammad, Hussain, Zeeshan, Adil, Syed Omair, Ansari, Ali H., Ansari, Usman H., Farooq, Fawad, Masqati, Noor-un-Nisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772794/ https://www.ncbi.nlm.nih.gov/pubmed/35477175 http://dx.doi.org/10.1182/bloodadvances.2022007031 |
Ejemplares similares
-
Reflection of treatment proficiency of hydroxyurea treated β-thalassemia serum samples through nuclear magnetic resonance based metabonomics
por: Khalid, Ayesha, et al.
Publicado: (2019) -
Hydroxyurea Treated β-Thalassemia Children Demonstrate a Shift in Metabolism Towards Healthy Pattern
por: Iqbal, Ayesha, et al.
Publicado: (2018) -
Molecular epidemiology of β-thalassemia in Pakistan: Far reaching implications
por: Ansari, Saqib H., et al.
Publicado: (2012) -
Alpha thalassemia deletions found in suspected cases of beta thalassemia major in Pakistani population
por: Shahid, Saba, et al.
Publicado: (2017) -
Watershed Infarct in Beta-Thalassemia Major Patient
por: Ansari, Behnaz, et al.
Publicado: (2017)